Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: Clinical and economic consequences

Annals of Internal Medicine

Volumn 126, Issue 4, 1997, Pages 280-291

  Ofman, Joshua J ^a   Etchason, Jeff ^b   Fullerton, Steven ^a   Kahn, Katherine L ^a   Soll, Andrew H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BISMUTH; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; RANITIDINE; TETRACYCLINE;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; COST EFFECTIVENESS ANALYSIS; DECISION THEORY; DYSPEPSIA; ENDOSCOPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031042099     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-126-4-199702150-00004     Document Type: Article

References (69)

1. Talley NJ. Colin-Jones D, Koch KL, Koch M, Nyren O. Stangheilini V. Functional dyspepsia: a classification with guidelines for diagnosis and management. Gastraenterology International. 1991;4:145-60.
2. Jones R, Lydeard S. Prevalence of symptoms of dyspepsia in the community. BMJ. 1989:298:30-2.
3. Drossman DA, Li Z, Andruzzi E, Temple RD. Talley NJ, Thompson WG, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993;38:1569-80.
4. Jones R, Lydeard S. Dyspepsia in the community: a follow-up study. Br J Clin Pract. 1992;46:95-7.
5. Marsland DW, Wood M, Mayo F. Content of family practice. Part I. Rank order of diagnoses by frequency. Part II. Diagnosis by disease category and age/sex distribution. J Fam Pract. 1976;3:37-68.
6. Endoscopy in the evaluation of dyspepsia. Health and Public Policy Committee. American College of Physicians. Ann Intern Med. 1985; 102:266-9.
7. Sipponen P, Hyvarinen H. Role of Helicobacter pylori in the pathogenesis of gastritis, peptic ulcer and gastric cancer. Scand J Gastroenterol Suppl. 1993; 196:3-6.
8. Graham DY, Lew GM, Klein PD, Evans DG, Evans DJ Saeed ZA. et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med. 1992;116:705-8.
9. Hentschel E. Brandstatter G, Dragosics B, Hirschl AM, Nemec H, Schütze K, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med. 1993;328:308-12.
10. Marshall BJ, Goodwin CS, Warren JR, Murray R, Blincow ED, Blackbourn SJ, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet. 1988;2:1437-42.
11. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA. 1994;272:65-9.
12. Talley NJ. The role of Helicobacter pylori in nonulcer dyspepsia. A debate - against. Gastroenterol Clin North Am. 1993;22:153-67.
13. Greenberg RE, Bank S. The prevalence of Helicobacter pylori in nonulcer dyspepsia. Importance of stratification according to age. Arch Intern Med. 1990;150:2053-5.
14. Johnsen R, Bernersen B, Straume B, Förde OH, Bostad L, Burhol PG. Prevalences of endoscopie and histological findings in subjects with and without dyspepsia. BMJ. 1991;302:749-52.
15. Talley NJ. A critique of therapeutic trials in Helicobacter py/on'-positive functional dyspepsia. Gastroenterology. 1994;106:1174-83.
16. Veldhuyzen van Zanten SJ. A systematic overview (meta-analysis) of out-come measures in Helicobacter pylori gastritis trials and functional dyspepsia. Scand J Gastroenterol Suppl. 1993;199:40-3.
17. Tham TC, McLaughlin N, Hughes DF, Ferguson M, Crosbie JJ, Madden M, et al. Possible role of Helicobacter pylori serology in reducing endoscopy workload. Postgrad Med J. 1994;70:809-12.
18. Patel P. Mendall MA, Khulusi S, Molineaux N, Levy J, Maxwell JD. et al. Salivary antibodies to Helicobacter pylori: screening dyspeptic patients before endoscopy. Lancet. 1994;344:511-2.
19. Sobala GM, Crobtree JE, Pentith JA, Rathbone BJ, Shallcross TM, Wyatt Jl, et al. Screening dyspepsia by serology to Helicobacter pylori. Lancet. 1991;338:94-6.
20. Patel P, Khulusi S, Mendall MA, Lloyd R, Jazrawi R, Maxwell JO, et al. Prospective screening of dyspeptic patients by Helicobacter pylori serology. Lancet. 1995:346:1315-8.
21. DATA version 2.5 Users' Manual. Boston: TreeAge Software; 1994.
22. O'Riordan TG, Tobin A, O'Morain C. Helicobacter pylori infection in elderly dyspeptic patients. Age Ageing. 1991;20:189-92.
23. Strauss RM, Wang TC Kelsey PB. Compton CC, Ferraro MJ, PerezPerez G, et al. Association of Helicobacter pylori infection with dyspeptic symptoms in patients undergoing gastroduodenoscopy. Am J Med. 1990,89:464-9.
24. Mendall MA. Jazrawi RP, Marrero JM, Molineaux N, Lev! J. Maxwell JD, et al. Serology for Helicobacter pylori compared with symptom questionnaires in screening before direct access endoscopy. Gut. 1995:36:330-3.
25. Loffeld RJ, Stobberingh E, Flendrig JA, Arends JW. Presence of Helicobacter pylori in patients with non-ulcer dyspepsia revealing normal antral histological characteristics. Digestion. 1990:47:29-34.
26. McCarthy C, Patchett S. Collins RM. Beattie S, Keane C, O'Morain C. Long-term prospective study of Helicobacter pylori in nonulcer dyspepsia. Dig Dis Sci. 1995;40:114-9.
27. Gad A, Hradsky M, Furugard K, Malmodin B, Nyberg O. Campylobacter pylori and non-ulcer dyspepsia. 2. A prospective study in a Swedish population. Scand J Gastroenterol Suppl. 1989:167:44-8.
28. Lambert The role of Helicobacter pylori in nonulcer dyspepsia. A debate-for. Gastroenterol Clin North Am. 1993;22:141-51.
29. Chiba N, Rao BV, Rademaker JW, Hunt RH. Meta-analysis of the efficacy of antibiotic therapy in eradicating He/icobacter pylori. Am J Gastroenterol. 1992:87:1716-27.
30. Labenz J, Stolte M, Ruhl GH, Becker T, Tillenburg B, Sollbohmer M, et al. One-week low-dose triple therapy for the eradication of Helicobacter pylori infection.- Eur J Gastroenterol Hepatol. 1995:7:9-11.
31. Kahn KL, Greenfield S. The efficacy of endoscopy in the evaluation of dyspepsia. A review of the literature and development of a sound strategy. J Clin Gastroenterol. 1986:8:346-58.
32. Mans! C, Mêla GS, Savarino V, Mêle MR, Valle F, Celle G. Open access endoscopy: a large-scale analysis of its use in dyspeptic patients. J Clin Gastroenterol. 1993:16:149-53; discussion 153-4.
33. Kagevi I, Lofstedt S, Persson LG. Endoscopie findings and diagnoses in unselected dyspeptic patients at a primary health care center. Scand J Gastroenterol. 1989:24:145-50.
34. Heikkinen M, Pikkarainen P, Takala J, Rasanen H, Julkunen R. Etiology of dyspepsia: four hundred unselected consecutive patients in general practice. Scand J Gastroenterol. 1995:30:519-23.
35. Reiertsen O, Skjoto J, Jacobsen CD, Rosseland AR. Complications of fiberoptic gastrointestinal endoscopy-five years' experience in a central hospital. Endoscopy. 1987:19:1-6.
36. Quine MA, Bell CD, McCloy RF, Matthews HR. Prospective audit of perforation rates following upper gastrointestinal endoscopy in two regions of England. Er J Surg. 1995;82:530-3.
37. Arrowsmith JB, Gerstman BB, Fleischer DE, Benjamin SB. Results from the American Society for Gastrointestinal Endoscopy/U.S. Food and Drug Administration collaborative study on complication rates and drug use during gastrointestinal endoscopy. Gastrointest Endosc. 1991:37:421-7.
38. Thijs JC. Van Zwet AA, Oey HB. Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori. Scand J Gastroenterol. 1993:28:934-8.
39. Dde Boaer WA, Tytgat GN. The best therapy for Helicobacter pylori infection: should efficacy or side-effect profile determine our choice? Scand J Gastroenterol. 1995:30:401-7.
40. Teare JP, Booth JC, Brown JL, Martin J, Thomas HC. Pseudomembranous colitis following clarithromycin therapy. Eur J Gastroenterol Hepatol. 1995;7: 275-7.
41. Soil AH. Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology. JAMA. 1996:275:622-9.
42. Malfertheiner P. Compliance, adverse events and antibiotic resistance in Helicobacter pylori treatment. Scand J Gastroenterol Suppl. 1993:196:34-7.
43. Hirschhorn LR, Trnka Y, Onderdonk A, Lee ML, Platt R. Epidemiology of community-acquired Clostridium d/ffic/'/e-associated diarrhea. J Infect Dis. 1994;169:127-33.
44. Cutler AF, Havstad S, Ma CK, Blaser MJ, Perez-Perez Gl, Schubert TT. Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology. 1995:109:136-41.
45. Conwell CF, Lyell R, Rodney WM. Prevalence of Helicobacter pylori in family practice patients with refractory dyspepsia: a comparison of tests available in the office. J Fam Pract. 1995:41:245-9.
46. Fuchs CS, Mayer RJ. Gastric carcinoma. N Engl J Med. 1995:333:32-41.
47. Hansen JM, Bytzer P, Bondesen S, Schaffalitzky de Muckadell OB. Efficacy and outcome of an open access endoscopy service. Dan Med Bull. 1991:38:288-90.
48. Davenport PM, Morgan AG, Darnborough A, De Dombai FT. Can preliminary screening of dyspeptic patients allow more effective use of investigational techniques? Br Med J (Clin Res Ed). 1985:290:217-20.
49. Imperiale TF, Speroff T, Cebul RD, McCullough AJ. A cost analysis of alternative treatments for duodenal ulcer. Ann Intern Med. 1995:123:665-72.
50. Kochman ML, Elta GH. Gastric ulcers-when is enough enough? Gastroenterology. 1993:105:1583-4.
51. Morris C, Chapman R, Mayou R. The outcome of unexplained dyspepsia. A questionnaire follow-up study of patients after endoscopy. J Psychosom Res. 1992:36:751-7.
52. Hungin AP, Thomas PR, Bramble MG, Corbett WA, Idle N, Contractor BR, et al. What happens to patients following open access gastroscopy? An outcome study from general practice. Br J Gen Pract. 1994:44:519-21.
53. Jones R. What happens to patients with non-ulcer dyspepsia after endoscopy? Practitioner. 1988:232:75-6, 78.
54. Fendrick AM, Chernew ME, Hirth RA, Bloom BS. Alternative management strategies for patients with suspected peptic ulcer disease. Ann Intern Med. 1995:123:260-8.
55. Silverstein MD, Petterson T, Talley NJ. Initial endoscopy or empirical therapy with or without testing for Helkobacter pylori for dyspepsia: a decision analysis. Gastroenterology. 1996;110:72-83.
56. Kunin CM. Resistance to antimicrobial drugs-a worldwide calamity. Ann Intern Med. 1993;118:557-61.
57. Noach LA, Ungenberg WL Bertola MA. Dankert J, Tytgat GN. Impact of metronidazole resistance on the eradication of Helicobacter pylori. Scand J Infect Dis. 1994;26:321-7.
58. Walsh JH, Peterson WL The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N Engl J Med. 1995;333:984-91.
59. Margolis HS, Coleman PJ, Brown RE, Mast EE, Sheingold SH. Arevalo JA. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations. JAMA. 1995;274:1201-8.
60. Bytzer P, Hansen JM, Schaffalitzky de Muckadell OB. Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet. 1994;343:811-6.
61. Goodson JD, Lehmann JW, Richter JM, Read JL, Atamian S, Colditz GA. Is upper gastrointestinal radiography necessary in the initial management of uncomplicated dyspepsia? A randomized controlled trial comparing empiric antacid therapy plus patient reassurance with traditional care. J Gen Intern Med. 1989;4:367-74.
62. Goulston KJ, Dent OF, Mant A, Lpgan J. Ngu M. Use of H2-receptor antagonists in patients with dyspepsia and heartburn: a cost comparison. Med J Aust. 1991;155:20-6.
63. Veldhuyzen van Zanten SJ, Sherman PM. Indications for treatment of Helicobacter pylori infection: a systematic overview. Can Med Assoc J. 1994; 150:189-98.
64. Labenz J, Borsch G. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection. Am J Gastroenterol. 1994;89:1785-8.
65. Jaup BH, Norrby A. Low dose, short-term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers. Am J Gastroenterol. 1995; 90:943-5.
66. Nyren O. Therapeutic trial in dyspepsia: its role in the primary care setting. Scand J Gastroenterol Suppl. 1991;182:61-9.
67. O'Connor HJ, Cunnane K. Helicobacter pylori and gastro-oesophageal reflux disease-a prospective study. Ir J Med Sci. 1994;163:369-73.
68. Pace F, Maconi G, Molten! P, Minguzzi M. Bianchi Porro G. Metaanalysis of the effect of placebo on the outcome of medically treated reflux esophagitis. Scand J Gastroenterol. 1995;30:101-5.
69. Iber FL, U'vak A, Kruss DM. Apnea and cardiopulmonary arrest during and after endoscopy. J Clin Gastroenterol. 1992;14:109-13.